Last reviewed · How we verify
NCT05268523
Self-Management Interventions for Long COVID-19
NA trial testing Education and Strategies Intervention in COVID-19 in 270 participants. Currently enrolling.
1 June 2025
Quick facts
| Lead sponsor | Toronto Rehabilitation Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 270 |
| Start date | 23 November 2021 |
| Primary completion | 1 June 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Education and Strategies Intervention
- Mindfulness Skills Intervention
Conditions studied
- COVID-19 — all drugs for COVID-19 →
Sponsor
Toronto Rehabilitation Institute
Who can join
18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate and compare the feasibility and efficacy of two group-based interventions (education vs. mindfulness) to help self-manage Long-COVID symptoms.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Neurological, psychological, psychosocial complications of long-COVID and their management.
Narayanan SN, Padiyath S, Chandrababu K, Raj L, et al · · 2025 · cited 7× · PMID 39516425 · DOI 10.1007/s10072-024-07854-5 -
Effectiveness of a personalised self-management intervention for people living with long covid (Listen trial): pragmatic, multicentre, parallel group, randomised controlled trial.
Busse M, Pallmann P, Riaz M, Potter C, et al · · 2025 · cited 6× · PMID 40046291 · DOI 10.1136/bmjmed-2024-001068 -
Self-managing symptoms of Long COVID: an education and strategies research protocol.
Rybkina J, Jacob N, Colella B, Gold D, et al · · 2024 · cited 4× · PMID 38384879 · DOI 10.3389/fpubh.2024.1106578
Verify or expand the search:
- PubMed search for NCT05268523
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Toronto Rehabilitation Institute trials
Trials by the same sponsor.
- NCT06657989 — Optimal Intensity of Reactive Balance Training for Healthy Older Adults · NA · recruiting
- NCT05986513 — Brain MRI for Knee OA · NA · unknown
- NCT05387213 — Nurse Practitioner Led Implementation of Team Huddles in Long-Term Care Homes · NA · completed
- NCT04361149 — Motor Unit Abnormalities After Experimentally Induced Sensitization · Phase 4 · completed
- NCT04042961 — Reactive Balance Training and Fitness · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05268523 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Toronto Rehabilitation Institute
- Last refreshed: 25 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05268523.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing